Consumer Medicine Information (CMI)
What is in this leaflet
This leaflet answers some common questions about Amaryl.
It does not contain all the available information. It does not take the place of talking to your doctor, pharmacist or diabetes educator.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking Amaryl against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.
You may need to read it again.
What it looks like
Amaryl 1 mg tablets: pink oblong, scored tablets with "NMK" and the Hoechst logo on both sides.
Amaryl 2 mg tablets: green oblong, scored tablets with "NMM" and the Hoechst logo on both sides.
Amaryl 3 mg tablets: pale yellow oblong, scored tablets with "NMN" and the Hoechst logo on both sides.
Amaryl 4 mg tablets: light blue oblong, scored tablets with "NMO" and the Hoechst logo on both sides.
The tablets are packed in blister packs of 30 tablets.
- magnesium stearate
- microcrystalline cellulose
- sodium starch glycollate
In order to distinguish between the different tablet strengths, each strength contains different colourings. These are:
- Amaryl 1 mg tablets - iron oxide red
- Amaryl 2 mg tablets - iron oxide yellow and indigo carmine lake
- Amaryl 3mg tablets - iron oxide yellow
- Amaryl 4 mg tablets - indigo carmine lake
Amaryl is made in Italy.
Amaryl is supplied in Australia by:
sanofi-aventis australia pty ltd
12-24 Talavera Road
Macquarie Park NSW 2113
This leaflet was prepared in January 2010.
Australian Registration Numbers:
Amaryl 1 mg: AUST R 57186
Amaryl 2 mg: AUST R 57189
Amaryl 3mg : AUST R 79334
Amaryl 4 mg: AUST R 57191